Evotec and Owkin combined AI target discovery with Evotec's R&D platform in oncology and immunology.

Owkin's target discovery engine feeds hypotheses to Evotec's end-to-end R&D platforms. A joint Research Strategy Team guides programs from target selection through IND filing. Evotec gets R&D funding, performance milestones and product royalties. The page gives no results.

Evotec is a drug discovery and development services company that pairs AI partners with its integrated R&D platform in oncology and immunology.

This sits in the Design & Stress-Test stage of the AI use-case lifecycle: Named examples from the tools pharma teams use to scope, prototype and benchmark an AI use case before committing to build it — data-catalog, sandbox and evaluation platforms.